For instance, IL-1 and TNF-α are often significantly elevated in MPNs, activating the NF-κB pathway by binding cell surface receptors in a variety of cell types, and inducing CD34+ cell survival and JAK2 V617F clonal expansion in MPN patients [117,118,119]. The gene discussed is NFKB1; the disease is myeloproliferative disorder.